Galera Therapeutics Inc (GRTX)
0.1989
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.1989
0.00 (0.00%)
Pre-Market: 20:00
Galera Therapeutics Total Liabilities (Quarterly): 154.34M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 154.34M |
| December 31, 2023 | 157.33M |
| September 30, 2023 | 164.33M |
| June 30, 2023 | 163.28M |
| March 31, 2023 | 157.33M |
| December 31, 2022 | 153.22M |
| September 30, 2022 | 148.22M |
| June 30, 2022 | 144.32M |
| March 31, 2022 | 141.57M |
| December 31, 2021 | 141.32M |
| September 30, 2021 | 141.93M |
| Date | Value |
|---|---|
| June 30, 2021 | 140.79M |
| March 31, 2021 | 81.06M |
| December 31, 2020 | 77.98M |
| September 30, 2020 | 73.38M |
| June 30, 2020 | 74.06M |
| March 31, 2020 | 77.76M |
| December 31, 2019 | 53.77M |
| September 30, 2019 | 224.38M |
| June 30, 2019 | 50.73M |
| December 31, 2018 | 192.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
50.73M
Minimum
Jun 2019
224.38M
Maximum
Sep 2019
126.05M
Average
141.75M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.65M |
| Shareholders Equity (Quarterly) | -134.69M |